USA Rare Earth (USAR) advances toward a 2028 mine launch, plans a Brazil acquisition, and eyes U.S. funding. Read the latest ...
Moby summary of Altimmune, Inc.'s Q1 2026 earnings call ...
Plans to submit a Marketing Authorization Application (MAA) to the EMA in Q3 2026 following alignment meetings with European ...
NDA Submission Status -- D-PLEX100 rolling New Drug Application was initiated with the FDA on March 30, 2026, with CMC, nonclinical, and administrative modules submitted, and the clinical module ...
Check Shanmuga Hospital Stock Price live NSE/BSE on financialexpress.com. Get Shanmuga Hospital today's stock price, 52-week high, 52-week low, Shanmuga Hospital quarterly results, share performance, ...
The Nifty 50 is expected to trade in the 24,000–24,500 range in the upcoming sessions, as a decisive breakout on either side ...
CORDStrom supply chain -- A new expanded material transfer agreement with Anthony Nolan U.K. Cord Blood Bank secures long-term umbilical cord supply for commercial manufacturing. XPro development -- ...
Indian markets closed sharply lower as SBI’s weaker-than-expected earnings triggered a broad selloff in banking and financial ...
Midcap index hits a record high above 62,000 as defence and auto stocks rally despite weak Sensex and Nifty benchmarks. Paras ...
Join us on the Axis Bank Stock Liveblog, your hub for real-time updates and comprehensive analysis on a prominent stock. Stay ...
Total Revenue -- $164.9 million, up from $157.2 million the previous year; reflects increasing prescriptions and patient volume. Prescription Trends -- Record levels of new prescriptions, new patient ...
The TAK-881-3001 clinical trial evaluated the PK, efficacy, safety, tolerability and immunogenicity of TAK-881 in adults and pediatric patients aged 2 years and older with PID previously treated with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results